跳至主要内容
临床试验/NL-OMON20626
NL-OMON20626已完成不适用

A randomised, controlled, double-blind study to investigate the effect of new infant formula on the incidence of gastrointestinal symptoms in healthy term infants.

Danone Research – Centre for Specialised Nutrition0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300

研究概览

简要总结

The combination of scGOS/lcFOS and fermented infant formula softens stools of infants compared to unfermented infant formula without scGOS/lcFOSscGOS/lcFOS. Herrera AR, Ludwig T, Bouritius H, Rubio RP, Muñoz A, Agosti M, Lista G, Corvaglia LT, Navero JL. J Pediatr Gastroenterol Nutr. 2015 Oct;61(4):516-7

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Healthy and term infants (gestational age ≥ 37 and ≤ 42 weeks);
  • 2. Infants who are exclusively formula fed (mothers who have chosen not to breastfeed or mothers who ceased breastfeeding by time of inclusion), or;

排除标准

  • 1. Infants fed with infant formula containing probiotics or synbiotics prior to study entry;
  • 2. Congenital condition and/or previous or current illness that could interfere with study;

研究者

发起方
Danone Research – Centre for Specialised Nutrition

相似试验

Prebiotic oligosaccharides and fermented formula... | 临床试验